Active	Status	Sponsor type	Region	Phase	Filter
27 Active 7 Inactive 34 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   - « July » « 2025 » M T W T F S S 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3   Show only changed items Enrollment:

Advanced Filters

7 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Buxbaum, James L
PERT-AP, NCT06477159: Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency	Recruiting	4	60	US	Pancrelipase Capsules, CREON	Ohio State University, University of Pittsburgh, University of Illinois Chicago, University of Southern California, New York University, AbbVie	Exocrine Pancreatic Insufficiency	12/26	07/27
CARPO, NCT04681066: A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS	Completed	2	216	US, RoW	CM-4620 Injectable Emulsion or CM-4620-IE, Auxora, Placebo	CalciMedica, Inc.	Acute Pancreatitis, Systemic Inflammatory Response Syndrome	05/24	05/24
ECLIPSE, NCT04136002: Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode	Active, not recruiting	N/A	44467	US		Guardant Health, Inc., Premier Research Group plc	Colorectal Cancer	03/24	12/25
Rodriguez, Alex
REMODEL-2, NCT05156281 / 2020-005929-89: Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)	Recruiting	3	800	Europe, Canada, Japan, US, RoW	Remibrutinib, LOU064, Teriflunomide	Novartis Pharmaceuticals, Novartis Pharma AG	Relapsing Multiple Sclerosis	04/26	10/30
Youssef, Fady
CARPO, NCT04681066: A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS	Completed	2	216	US, RoW	CM-4620 Injectable Emulsion or CM-4620-IE, Auxora, Placebo	CalciMedica, Inc.	Acute Pancreatitis, Systemic Inflammatory Response Syndrome	05/24	05/24
Vazquez, Alejandro
PERT-AP, NCT06477159: Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency	Recruiting	4	60	US	Pancrelipase Capsules, CREON	Ohio State University, University of Pittsburgh, University of Illinois Chicago, University of Southern California, New York University, AbbVie	Exocrine Pancreatic Insufficiency	12/26	07/27
CARPO, NCT04681066: A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS	Completed	2	216	US, RoW	CM-4620 Injectable Emulsion or CM-4620-IE, Auxora, Placebo	CalciMedica, Inc.	Acute Pancreatitis, Systemic Inflammatory Response Syndrome	05/24	05/24

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Buxbaum, James L
PERT-AP, NCT06477159: Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency	Recruiting	4	60	US	Pancrelipase Capsules, CREON	Ohio State University, University of Pittsburgh, University of Illinois Chicago, University of Southern California, New York University, AbbVie	Exocrine Pancreatic Insufficiency	12/26	07/27
CARPO, NCT04681066: A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS	Completed	2	216	US, RoW	CM-4620 Injectable Emulsion or CM-4620-IE, Auxora, Placebo	CalciMedica, Inc.	Acute Pancreatitis, Systemic Inflammatory Response Syndrome	05/24	05/24
ECLIPSE, NCT04136002: Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode	Active, not recruiting	N/A	44467	US		Guardant Health, Inc., Premier Research Group plc	Colorectal Cancer	03/24	12/25
Rodriguez, Alex
REMODEL-2, NCT05156281 / 2020-005929-89: Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)	Recruiting	3	800	Europe, Canada, Japan, US, RoW	Remibrutinib, LOU064, Teriflunomide	Novartis Pharmaceuticals, Novartis Pharma AG	Relapsing Multiple Sclerosis	04/26	10/30
Youssef, Fady
CARPO, NCT04681066: A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS	Completed	2	216	US, RoW	CM-4620 Injectable Emulsion or CM-4620-IE, Auxora, Placebo	CalciMedica, Inc.	Acute Pancreatitis, Systemic Inflammatory Response Syndrome	05/24	05/24
Vazquez, Alejandro
PERT-AP, NCT06477159: Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency	Recruiting	4	60	US	Pancrelipase Capsules, CREON	Ohio State University, University of Pittsburgh, University of Illinois Chicago, University of Southern California, New York University, AbbVie	Exocrine Pancreatic Insufficiency	12/26	07/27
CARPO, NCT04681066: A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS	Completed	2	216	US, RoW	CM-4620 Injectable Emulsion or CM-4620-IE, Auxora, Placebo	CalciMedica, Inc.	Acute Pancreatitis, Systemic Inflammatory Response Syndrome	05/24	05/24